Table 1.
Clinicopathological characteristics of 204 patients with NMIBC.
| Characteristics | No. (%) of cases |
|---|---|
| Sex | |
| Male | 161 (78.9) |
| Female | 43 (21.1) |
| Age (mean, range, yrs) | 61.6 (30-88) ± 11.1 |
| Male | 61.5 (30-88) ± 11.0 |
| Female | 62.1 (34-88) ± 11.6 |
| pT stage | |
| Ta | 166 (81.4) |
| T1 | 38 (18.6) |
| Tumor grade | |
| Low grade | 110 (53.9) |
| High grade | 94 (46.1) |
| HER2 protein expression (IHC) | |
| 0 | 44 (21.6) |
| 1+ | 58 (28.4) |
| 2+ | 91 (44.6) |
| 3+ | 11 (5.4) |
| Number of tumors | |
| Single | 138 (67.6) |
| 2-7 | 54 (26.5) |
| ≥8 | 12 (5.9) |
| Tumor size | |
| < 3 cm | 190 (93.1) |
| ≥ 3 cm | 14 (6.9) |
NMIBC, non-muscle invasive bladder cancer; HER-2, human epidermal growth factor receptor-2.